Agenda

• Leadership
• HR Organization (hybrid working)
• New performance management approach
• New Talent management approach

It is an ongoing rollercoaster that challenges governments, nonprofits, and corporate environments. However, there is always an opportunity to thrive in uncertain times by leveraging key insights into utilizing intelligence about the future to anticipate change, understanding the various types of emergence, and avoiding disruption by imagining and building new global scenarios where humans collaborate with AI to understand emerging issues.

However, staying on top of competitive intelligence requires an investment which grows over time. Therefore, it is imperative that an organization sees the value of CI. The Molekule team will provide an overview of how to demonstrate the value of CI by empowering your organization with the takeaways and tactics they need to improve decision-making and execution.

• Advance your understanding of core regulatory routes, timelines and strategies
• Understand core Gx/biosimilar product development and entry strategies
• Learn from & set up a best-in-industry Gx/biosimilar regulatory intelligence (RI) and CI tracking program
The presentation will be supported by thought provoking real-world case studies to stress differences between theory vs actual approaches

• Understand how competitors perceive and prioritize key access challenges and their approaches to address them
• Identify GTM activities and strategies that address healthcare systems’ needs and how they are implemented throughout the development and launch of the product
• Assess how success is measured and benchmark by competitors, payers, patients and prescribers

Case studies will be discussed as well as practical implementation of such department, and how it fuels the strategic decision-making at C-suite level or contributes to the dissemination of strategic CI mindset/methodology/tools across the different functions.

From the innovators and disruptors, to socio-geo-political aspects, and looking economic uncertainty, we will apply a comprehensive lens to this year’s challenges and potential implications, in order that global CI practitioners remain agile and poised to navigate the dynamics of 2023 and beyond.

Clinical trials have followed the ‘cave-(wo)man’ test since their inception. Patient takes drug and is compared to patient who doesn’t take drug. However, the gains for this process for new medicine development is diminishing. AI is revolutionising supply chains across industries, and clinical trials are no exception. Join us in Rome to hear how AI will enable faster, safer, and significantly less expensive clinical trials. Discover what the future may lie ahead for clinical trials in silico, learn what is an N=1 trial and how this paves the way for the future of personalised medicine.

No longer can competitor, market and stakeholder intelligence be delivered on an ad hoc basis in a format that is difficult to decipher; decision-makers require dynamic, targeted, high-impact insight that provides clarity and empowers them to act in a timely manner.

• Is BI standard part of core project team or only ad hoc guest?
• How do you deliver/report your findings?
• Tips on how to get more involved (proactive vs reactive approach)

While market research is squarely focused on the “customers” piece of the equation, competitive intelligence provides crucial insight into the way the market shifts as a result of competitor activity. Through this talk, we explain, with the help of some examples, when and how CI can be interwoven into market research to unlock a unique perspective of the market that is not only more comprehensive but also more forward-looking and actionable.

The traditional CI model of gathering intelligence and generating insights is not enough. Developing, launching and growing blockbuster brands require a well defined strategic decision making process.

In this presentation, we will share our proven 3 step process needed to identify your key competitors, assess several credible scenarios, determine risks and opportunities, identify the key success factors, and create an action plan to execute within your winning strategy.

The presentation incorporates learnings from leading the CI functions at Roche and Novartis, supporting the majority of Big Pharma companies CI efforts, the latest management thinking from Harvard Business School, and years of cross-functional experience within Pharma and at Atacana.

We look forward to seeing you there!

• Information management from public domain: sifting through the ‘noise’
• Using the hybrid of technology and human touch to create successful outcomes
• Case study: ASCO2022

• Is BI standard part of core project team or only ad hoc guest?
• How do you deliver/report your findings?
• Tips on how to get more involved (proactive vs reactive approach)

In this talk, we will explore the use of neuromarketing techniques in the medical industry and how they can help us understand the unconscious emotions that influence medical decision making. We will present a series of case studies that reveal the emotional components driving medical decision making, and explore how this knowledge can be used to improve marketing strategies and communication in the medical industry.

Moreover, we will discuss the challenges of implementing neuromarketing techniques in the medical industry, including ethical considerations and the need for specialized training. However, the potential benefits of using these techniques to understand the unconscious emotions of patients and physicians far outweigh these challenges.

By the end of this talk, attendees will have a greater understanding of how neuromarketing techniques can be used to understand unconscious emotions in medical decision making. They will also gain insights into how to develop more effective marketing strategies and communication that appeal to the emotional and intuitive responses of both physicians and patients, ultimately leading to more successful engagement and increased sales.

Overall, this talk will provide valuable insights into the power of neuromarketing techniques to improve marketing and communication in the medical industry, and how understanding the unconscious emotions of patients and physicians is key to success in this field.